Toxicity of amphetamines: an update

@article{Carvalho2012ToxicityOA,
  title={Toxicity of amphetamines: an update},
  author={M{\'a}rcia Carvalho and Helena Carmo and Vera Marisa Costa and Jo{\~a}o Paulo Capela and Helena Pontes and Fernando Remi{\~a}o and F{\'e}lix Carvalho and Maria de Lourdes Bastos},
  journal={Archives of Toxicology},
  year={2012},
  volume={86},
  pages={1167-1231}
}
Amphetamines represent a class of psychotropic compounds, widely abused for their stimulant, euphoric, anorectic, and, in some cases, emphathogenic, entactogenic, and hallucinogenic properties. These compounds derive from the β-phenylethylamine core structure and are kinetically and dynamically characterized by easily crossing the blood–brain barrier, to resist brain biotransformation and to release monoamine neurotransmitters from nerve endings. Although amphetamines are widely acknowledged as… 

On the necessity of translational cognitive-neurotoxicological research in methamphetamine abuse and addiction

Transgenerational effects of METH exposure are shown by looking at how neurotoxic effects ofMETH administered in utero alter various neurotransmitter levels.

The mixture of “ecstasy” and its metabolites is toxic to human SH-SY5Y differentiated cells at in vivo relevant concentrations

It is demonstrated, for the first time, that the mixture of MDMA and its metabolites, at low micromolar concentrations, which represents a more realistic approach of the in vivo scenario, elicited toxicity to human SH-SY5Y differentiated cells, thus constituting a new insight into the context of MDMA-related neurotoxicity.

Medicinal and Therapeutic Properties of Ephedra

A systematic search was performed to provide animal and clinical evidence regarding the therapeutic effects of the Ephedra herb and a vast diversity of alkaloid and non-alkaloid compounds have been known in different species of Ephedro.

Altered metabolic pathways elucidated via untargeted in vivo toxicometabolomics in rat urine and plasma samples collected after controlled application of a human equivalent amphetamine dose

The present study complements previous data and shows that several studies are necessary to elucidate altered metabolic pathways associated with acute amphetamine exposure and demonstrate a downregulation of amino acids in plasma samples after Amphetamine exposure.

An updated review on synthetic cathinones

The present work provides a comprehensive review on history and legal status, chemistry, pharmacokinetics, pharmacodynamics, adverse effects and lethality in humans, as well as on the current knowledge of the neurotoxic mechanisms of synthetic cathinones.

From street to lab: in vitro hepatotoxicity of buphedrone, butylone and 3,4-DMMC

Butylone, buphedrone and 3,4-DMMC have hepatotoxic potential, and their toxicity lies in the interference with a number of homeostatic processes, while being influenced by their metabolic fate.

Adverse outcome pathways induced by 3,4-dimethylmethcathinone and 4-methylmethcathinone in differentiated human SH-SY5Y neuronal cells

The mitochondrial impairment and oxidative stress observed for the tested cathinones may be key factors for their neurotoxicity, but different outcome pathways seem to be involved in the adverse effects, when compared to METH.

Metabolic signature of methylone in primary mouse hepatocytes, at subtoxic concentrations

A metabolomics approach based on gas chromatography–mass spectrometry combined with chemometric analyses was used to characterize the disturbances occurring in the intra- and extracellular metabolome of primary mouse hepatocytes exposed to two subtoxic concentrations of methylone to better understand the early hepatotoxic events.

Emerging threats in addiction: will novel psychoactive substances contribute to exacerbating the ongoing drug overdose epidemic?

It is worth noting that the widespread emergence of NPS has coincided with a widespread increase in the abuse of opioid drugs, in the USA and elsewhere, and consequent overdoses from these drugs in epidemic proportions.

GC–MS metabolomics reveals disturbed metabolic pathways in primary mouse hepatocytes exposed to subtoxic levels of 3,4-methylenedioxymethamphetamine (MDMA)

The results highlight the potential of the intra- and extracellular metabolome to study alterations triggered by subtoxic concentrations of MDMA in hepatic cell functions, which represents a more realistic appraisal of early toxicity events posed by exposure to this drug.